• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

FPH Appendix 3B12/04/18
FPH Notification of Issue of Securities11/04/18
FPH Appendix 3B11/04/18
FPH Notification of Issue of Securities10/04/18
FPH Appendix 3B10/04/18
FPH Notification of Issue of Securities09/04/18
FPH Appendix 3B09/04/18
FPH Disclosure Document04/04/18
FPH Notification of Issue of Securities04/04/18
FPH Appendix 3B04/04/18
FPH Notification of Issue of Securities27/03/18
FPH Appendix 3B27/03/18
FPH Ground Breaking Research Shows Efficacy of Optiflow NHF23/03/18
FPH Notification of Issue of Securities09/03/18
FPH Appendix 3B09/03/18
FPH Notification of Issue of Securities05/03/18
FPH Appendix 3B05/03/18
FPH Notification of Issue of Securities22/02/18
FPH Appendix 3B22/02/18
FPH FPH's CFO Tony Barclay Announces Intention to Retire21/02/18
FPH Notification of Issue of Securities14/02/18
FPH Appendix 3B14/02/18
FPH FPH Presentation to the NZ Shareholders' Association13/02/18
FPH FPH Presentation to the NZ Shareholders' Association13/02/18
FPH Notification of Issue of Securities08/02/18
FPH Appendix 3B08/02/18
FPH Notification of Issue of Securities19/01/18
FPH Appendix 3B19/01/18
FPH Notification of Issue of Securities11/01/18
FPH Appendix 3B11/01/18
FPH Notification of Issue of Securities10/01/18
FPH Appendix 3B10/01/18
FPH Notification of Issue of Securities09/01/18
FPH Appendix 3B09/01/18
FPH Notification of Issue of Securities08/01/18
FPH Appendix 3B08/01/18
FPH Notification of Issue of Securities08/01/18
FPH Appendix 3B08/01/18
FPH Notification of Issue of Securities21/12/17
FPH Appendix 3B21/12/17
FPH Disclosure Document21/12/17
FPH Notification of Issue of Securities20/12/17
FPH Appendix 3B20/12/17
FPH Notification of Issue of Securities20/12/17
FPH Appendix 3B20/12/17
FPH Directors Interest Notice18/12/17
FPH FPH Building Programme Underway in New Zealand18/12/17
FPH Disclosure Document15/12/17
FPH Notification of Issue of Securities15/12/17
FPH Appendix 3B15/12/17
FPH Update - Dividend/Distribution - FPH14/12/17
FPH Dividend Reinvestment Plan Strike Price & AUD FX Rate14/12/17
FPH Notification of Issue of Securities13/12/17
FPH Appendix 3B13/12/17
FPH Notification of Issue of Securities13/12/17
FPH Appendix 3B13/12/17
FPH FPH Files Patent Infringement Proceeding Against ResMedPRICE SENSITIVE12/12/17
FPH Disclosure of Directors and Senior Managers Relevant Interes06/12/17
FPH Notification of Issue of Securities05/12/17
FPH Appendix 3B05/12/17
FPH Ceasing to be a substantial holder04/12/17
FPH Notification of Issue of Securities29/11/17
FPH Appendix 3B29/11/17
FPH Notification of Issue of Securities27/11/17
FPH Appendix 3B27/11/17
FPH Update - Dividend/Distribution - FPHPRICE SENSITIVE23/11/17
FPH Update - Dividend/Distribution - FPHPRICE SENSITIVE22/11/17
FPH Notification of Issue of Securities22/11/17
FPH Appendix 3B22/11/17
FPH Dividend/Distribution - FPH21/11/17
FPH Strong Half Year Result from FPH Record Net Profit NZ$81.3MPRICE SENSITIVE21/11/17
FPH Notification of Issue of Securities17/11/17
FPH Appendix 3B17/11/17
FPH Notification of Issue of Securities15/11/17
FPH Appendix 3B15/11/17
FPH Statement by ResMed on UK Case with Fisher & Paykel13/11/17
FPH FPH wins patent case against ResMed in UK court13/11/17
FPH Fisher & Paykel Healthcare CSR Report08/11/17
FPH Fisher & Paykel Healthcare Publishes CSR Report08/11/17
FPH Notification of Issue of Securities03/11/17
FPH Appendix 3B03/11/17
FPH FPH to Announce Half Year Results on 21 November 201702/11/17
FPH Notification of Issue of Securities01/11/17
FPH Appendix 3B01/11/17
FPH Notification of Issue of Securities30/10/17
FPH Appendix 3B30/10/17
FPH Appendix 3B27/10/17
FPH Notification of Issue of Securities27/10/17
FPH Appendix 3B26/10/17
FPH Notification of Issue of Securities26/10/17
FPH Appendix 3B25/10/17
FPH Notification of Issue of Securities25/10/17
FPH Appendix 3B24/10/17
FPH Notification of Issue of Securities24/10/17
FPH FPH Investor Day in Sydney Presentation Part Two16/10/17
FPH FPH Investor Day in Sydney Presentation Part One16/10/17
FPH Fisher & Paykel Healthcare Hosts Investor Day in Sydney16/10/17
FPH Notification of Issue of Securities16/10/17
FPH Appendix 3B16/10/17
FPH RMD: Update on German Patent Case Brought by Fisher & Paykel13/10/17
FPH Appendix 3B
12/04/18
FPH Notification of Issue of Securities
11/04/18
FPH Appendix 3B
11/04/18
FPH Notification of Issue of Securities
10/04/18
FPH Appendix 3B
10/04/18
FPH Notification of Issue of Securities
09/04/18
FPH Appendix 3B
09/04/18
FPH Disclosure Document
04/04/18
FPH Notification of Issue of Securities
04/04/18
FPH Appendix 3B
04/04/18
FPH Notification of Issue of Securities
27/03/18
FPH Appendix 3B
27/03/18
FPH Ground Breaking Research Shows Efficacy of Optiflow NHF
23/03/18
FPH Notification of Issue of Securities
09/03/18
FPH Appendix 3B
09/03/18
FPH Notification of Issue of Securities
05/03/18
FPH Appendix 3B
05/03/18
FPH Notification of Issue of Securities
22/02/18
FPH Appendix 3B
22/02/18
FPH FPH's CFO Tony Barclay Announces Intention to Retire
21/02/18
FPH Notification of Issue of Securities
14/02/18
FPH Appendix 3B
14/02/18
FPH FPH Presentation to the NZ Shareholders' Association
13/02/18
FPH FPH Presentation to the NZ Shareholders' Association
13/02/18
FPH Notification of Issue of Securities
08/02/18
FPH Appendix 3B
08/02/18
FPH Notification of Issue of Securities
19/01/18
FPH Appendix 3B
19/01/18
FPH Notification of Issue of Securities
11/01/18
FPH Appendix 3B
11/01/18
FPH Notification of Issue of Securities
10/01/18
FPH Appendix 3B
10/01/18
FPH Notification of Issue of Securities
09/01/18
FPH Appendix 3B
09/01/18
FPH Notification of Issue of Securities
08/01/18
FPH Appendix 3B
08/01/18
FPH Notification of Issue of Securities
08/01/18
FPH Appendix 3B
08/01/18
FPH Notification of Issue of Securities
21/12/17
FPH Appendix 3B
21/12/17
FPH Disclosure Document
21/12/17
FPH Notification of Issue of Securities
20/12/17
FPH Appendix 3B
20/12/17
FPH Notification of Issue of Securities
20/12/17
FPH Appendix 3B
20/12/17
FPH Directors Interest Notice
18/12/17
FPH FPH Building Programme Underway in New Zealand
18/12/17
FPH Disclosure Document
15/12/17
FPH Notification of Issue of Securities
15/12/17
FPH Appendix 3B
15/12/17
FPH Update - Dividend/Distribution - FPH
14/12/17
FPH Dividend Reinvestment Plan Strike Price & AUD FX Rate
14/12/17
FPH Notification of Issue of Securities
13/12/17
FPH Appendix 3B
13/12/17
FPH Notification of Issue of Securities
13/12/17
FPH Appendix 3B
13/12/17
FPH FPH Files Patent Infringement Proceeding Against ResMed
12/12/17PRICE SENSITIVE
FPH Disclosure of Directors and Senior Managers Relevant Interes
06/12/17
FPH Notification of Issue of Securities
05/12/17
FPH Appendix 3B
05/12/17
FPH Ceasing to be a substantial holder
04/12/17
FPH Notification of Issue of Securities
29/11/17
FPH Appendix 3B
29/11/17
FPH Notification of Issue of Securities
27/11/17
FPH Appendix 3B
27/11/17
FPH Update - Dividend/Distribution - FPH
23/11/17PRICE SENSITIVE
FPH Update - Dividend/Distribution - FPH
22/11/17PRICE SENSITIVE
FPH Notification of Issue of Securities
22/11/17
FPH Appendix 3B
22/11/17
FPH Dividend/Distribution - FPH
21/11/17
FPH Strong Half Year Result from FPH Record Net Profit NZ$81.3M
21/11/17PRICE SENSITIVE
FPH Notification of Issue of Securities
17/11/17
FPH Appendix 3B
17/11/17
FPH Notification of Issue of Securities
15/11/17
FPH Appendix 3B
15/11/17
FPH Statement by ResMed on UK Case with Fisher & Paykel
13/11/17
FPH FPH wins patent case against ResMed in UK court
13/11/17
FPH Fisher & Paykel Healthcare CSR Report
08/11/17
FPH Fisher & Paykel Healthcare Publishes CSR Report
08/11/17
FPH Notification of Issue of Securities
03/11/17
FPH Appendix 3B
03/11/17
FPH FPH to Announce Half Year Results on 21 November 2017
02/11/17
FPH Notification of Issue of Securities
01/11/17
FPH Appendix 3B
01/11/17
FPH Notification of Issue of Securities
30/10/17
FPH Appendix 3B
30/10/17
FPH Appendix 3B
27/10/17
FPH Notification of Issue of Securities
27/10/17
FPH Appendix 3B
26/10/17
FPH Notification of Issue of Securities
26/10/17
FPH Appendix 3B
25/10/17
FPH Notification of Issue of Securities
25/10/17
FPH Appendix 3B
24/10/17
FPH Notification of Issue of Securities
24/10/17
FPH FPH Investor Day in Sydney Presentation Part Two
16/10/17
FPH FPH Investor Day in Sydney Presentation Part One
16/10/17
FPH Fisher & Paykel Healthcare Hosts Investor Day in Sydney
16/10/17
FPH Notification of Issue of Securities
16/10/17
FPH Appendix 3B
16/10/17
FPH RMD: Update on German Patent Case Brought by Fisher & Paykel
13/10/17
(20min delay)
Last
$34.39
Change
0.870(2.60%)
Mkt cap ! $20.09B
Open High Low Value Volume
$33.91 $34.85 $33.54 $14.62M 425.3K

Buyers (Bids)

No. Vol. Price($)
2 784 $34.37
 

Sellers (Offers)

Price($) Vol. No.
$34.44 226 1
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
Last
$34.50
  Change
0.870 ( 2.69 %)
Open High Low Volume
$33.62 $34.85 $33.51 120085
Last updated 15.59pm 22/11/2024 ?
FPH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.